Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma
Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma
Mariana Feiges, Anne‐Laure Demessant‐Flavigny, Alessandro Nascimento, Thierry Passeron et al.
Citations
2 citations
Journal
Dermatology and Therapy
Topics
Dermatologic Treatments and Research
Field-Weighted Citation Impact (FWCI)
4.01
article
Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma
Mariana Feiges, Anne‐Laure Demessant‐Flavigny, Alessandro Nascimento, Thierry Passeron, Delphine Kérob, Andrew F Alexis, Renato José de Moura, Samir Salah, Érika Fernández, Guénaëlle Le Dantec
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Dermatology and TherapyVol. 15(9)
Institutions
Inserm (FR), Cornell University (US), CIDP Biotech (India) (IN), La Roche College (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma — Mariana Feiges, Anne‐Laure Demessant‐Flavigny, et al. · Dermatology and Therapy (2025) | TGRS Research Map | TGRS